Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?
Abstract
Author
Citations
Altmetric:
Date
2022-08
Type
Article
Subject
Venous thromboembolism, Inflammatory arthritis, Janus kinase (JAK) inhibitors
Collections
Citation
Jubber, A., Woodward, J., Tahir, H., & Moorthy, A. (2022). Venous thromboembolism risk with Janus kinase inhibitors: Is it a class wide effect?. Expert opinion on drug safety, 21(8), 1005–1007.